Executive Summary
Azoth Analytics has released a research report titled "Global Obesity Market (2023 Edition)" which provides a complete analysis of the Global Obesity Industry By Drug Type (Appetite Suppressants, Combination Drugs, Malabsorption Drugs, Other Drugs), Age Group (0-18 years, 19-39 years, 40-59 years, Above 60 years), Gender (Male, Female) for the historical period of 2019-2022, the estimates of 2023 and the forecast period of 2024-2029.
The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East and Africa) and 10 countries (United States, Canada, Brazil, United Kingdom, Germany, France, Italy, Spain, China, Japan). Additionally, the research report presents data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast.
The research report also assesses growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market's evolution.
During the forecast period, 2024-2029, the Global Obesity Market is expected to expand at a CAGR of 14.4%. The rising population, as well as the limited awareness and education about the importance of healthy eating and physical activity, are driving the Global Obesity Market. The Global Obesity Market is expected to generate USD 61.7 billion by the end of 2029, up from USD 25.24 billion in 2022. Changing dietary habits, globalization and food availability, have emerged as key drivers for the global obesity market.
The global obesity epidemic has become one of the most pressing public health challenges of the 21st century. With increasing prevalence rates across all age groups and geographical regions, obesity has significant implications for individuals, healthcare systems, and societies at large. The research study delves into the complexities of the global obesity market, examining the drivers, restraints, and trends shaping the landscape. It also explores innovative solutions and strategies aimed at curbing obesity's rise and fostering a healthier future.
Changing dietary habits have a profound impact on the global obesity market. As people across the world adopt new eating patterns and food choices, the prevalence of obesity and overweight has been on the rise. It often involves the consumption of energy-dense, nutrient-poor foods that are high in calories, sugars, and unhealthy fats. These foods can lead to an energy imbalance, where individuals consume more calories than they expend, resulting in weight gain and obesity.
Changing dietary habits in the Asia Pacific region have had a significant impact on the prevalence of obesity and overweight, leading to an escalating obesity market in the region. As urbanization and globalization continue, traditional dietary practices are sometimes replaced by more convenient and processed food options. This shift can result in a decline in the consumption of nutrient-rich traditional foods, leading to nutritional imbalances.
Scope of the Report
• The report analyses the Global Obesity Market by Value (USD Billion).
• The report presents the analysis of the Global Obesity Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.
• The report analyses the Global Obesity Market by Gender (Male and Female).
• The report analyses the Global Obesity Market by Drug Type (Appetite Suppressants, Combination Drugs, Malabsorption Drugs and Others).
• The report analyses the Global Obesity Market by Age Group (0 - 18 Years, 19 - 39 Years, 40 - 59 Years and Above 60 years).
• The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by Gender, by drug type and by age group.
• Also, the major opportunities, trends, drivers and challenges of the industry have been analyzed in the report.
• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Novo Nordisk, Eli Lilly and Company, Altimmune, Amgen, Carmot, Novartis, Zealand Pharma, AstraZeneca, Sciwind Biosciences and Bristol Myers Squibb.
1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology
2. Analyst Recommendations
2.1 Focus on Education & Awareness
2.2 Focus on Telemedicine & Digital Health Solutions
3. Global Obesity Market: Historic and Forecast (2019-2029)
3.1 Impact Analysis of Macro Economic Factors on the Obesity Market
3.2 Number of Deaths by Risk Factors Including Obesity, World, 2019
3.3 Prevalence of Adult Obesity
3.4 Global Percentage of Adults Facing Obesity as Biggest Health Problem, 2022
3.5 Biggest Health Problems among People Worldwide, 2022
3.6 Global Obesity Market: Dashboard
3.7 Global Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
3.8 Global Impact of COVID-19 on Obesity Market
3.9 Global Obesity Market Segmentation: By Gender
3.9.1 Global Obesity Market, By Gender Overview
3.9.2 Global Obesity Market Size, By Male, By Value, 2019H-2029F (USD Billion & CAGR)
3.9.3 Global Obesity Market Size, By Female, By Value, 2019H-2029F (USD Billion & CAGR)
3.10 Global Obesity Market Segmentation: By Drug Type
3.10.1 Global Obesity Market, By Drug Type Overview
3.10.2 Global Obesity Market Size, By Appetite Suppressants, By Value, 2019H-2029F (USD Billion & CAGR)
3.10.3 Global Obesity Market Size, By Combination Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
3.10.4 Global Obesity Market Size, By Malabsorption Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
3.10.4 Global Obesity Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
3.11 Global Obesity Market Segmentation: By Age Group
3.11.1 Global Obesity Market, By Age Group Overview
3.11.2 Global Obesity Market Size, 0-18 Years, By Value, 2019H-2029F (USD Billion & CAGR)
3.11.3 Global Obesity Market Size, 19-39 Years, By Value, 2019H-2029F (USD Billion & CAGR)
3.11.4 Global Obesity Market Size, 40-59 Years, By Value, 2019H-2029F (USD Billion & CAGR)
3.11.5 Global Obesity Market Size, Above 60 Years, By Value, 2019H-2029F (USD Billion & CAGR)
4. Obesity Market, Regional Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot
5. Americas Obesity Market: Historic and Forecast (2019-2029)
5.1 Americas Obesity Market: Snapshot
5.2 Americas Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.3 Americas Obesity Market: Key Factors
5.4 Americas Obesity Market Segmentation: By Gender
5.4.1 Americas Obesity Market, By Gender Overview
5.4.2 Americas Obesity Market Size, By Male, By Value, 2019H-2029F (USD Billion & CAGR)
5.4.3 Americas Obesity Market Size, By Female, By Value, 2019H-2029F (USD Billion & CAGR)
5.5 Americas Obesity Market Segmentation: By Drug Type
5.5.1 Americas Obesity Market, By Drug Type Overview
5.5.2 Americas Obesity Market Size, By Appetite Suppressants, By Value, 2019H-2029F (USD Billion & CAGR)
5.5.3 Americas Obesity Market Size, By Combination Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
5.5.4 Americas Obesity Market Size, By Malabsorption Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
5.5.5 Americas Obesity Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
5.6 Americas Obesity Market Segmentation: By Age Group
5.6.1 Americas Obesity Market, By Age Group Overview
5.6.2 Americas Obesity Market Size, 0-18 Years, By Value, 2019H-2029F (USD Billion & CAGR)
5.6.3 Americas Obesity Market Size, 19-39 Years, By Value, 2019H-2029F (USD Billion & CAGR)
5.6.4 Americas Obesity Market Size, 40-59 Years, By Value, 2019H-2029F (USD Billion & CAGR)
5.6.5 Americas Obesity Market Size, Above 60 Years, By Value, 2019H-2029F (USD Billion & CAGR)
5.7 Americas Obesity Market Segmentation: By Country
5.7.1 United States Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.7.1.1 United States Obesity Market, By Gender
5.7.1.2 United States Obesity Market, By Drug Type
5.7.1.3 United States Obesity Market, By Age Group
5.7.2 Canada Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.7.2.1 Canada Obesity Market, By Gender
5.7.2.2 Canada Obesity Market, By Drug Type
5.7.2.3 Canada Obesity Market, By Age Group
5.7.3 Brazil Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.7.3.1 Brazil Obesity Market, By Gender
5.7.3.2 Brazil Obesity Market, By Drug Type
5.7.3.3 Brazil Obesity Market, By Age Group
5.7.4 Rest of Americas Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.7.4.1 Rest of Americas Obesity Market, By Gender
5.7.4.2 Rest of Americas Obesity Market, By Drug Type
5.7.4.3 Rest of Americas Obesity Market, By Age Group
6. Europe Obesity Market: Historic and Forecast (2019-2029)
6.1 Europe Obesity Market: Snapshot
6.2 Europe Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.3 Europe Obesity Market: Key Factors
6.4 Europe Obesity Market Segmentation: By Gender
6.4.1 Europe Obesity Market, By Gender Overview
6.4.2 Europe Obesity Market Size, By Male, By Value, 2019H-2029F (USD Billion & CAGR)
6.4.3 Europe Obesity Market Size, By Female, By Value, 2019H-2029F (USD Billion & CAGR)
6.5 Europe Obesity Market Segmentation: By Drug Type
6.5.1 Europe Obesity Market, By Drug Type Overview
6.5.2 Europe Obesity Market Size, By Appetite Suppressants, By Value, 2019H-2029F (USD Billion & CAGR)
6.5.3 Europe Obesity Market Size, By Combination Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
6.5.4 Europe Obesity Market Size, By Malabsorption Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
6.5.4 Europe Obesity Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
6.6 Europe Obesity Market Segmentation: By Age Group
6.6.1 Europe Obesity Market, By Age Group Overview
6.6.2 Europe Obesity Market Size, 0-18 Years, By Value, 2019H-2029F (USD Billion & CAGR)
6.6.3 Europe Obesity Market Size, 19-39 Years, By Value, 2019H-2029F (USD Billion & CAGR)
6.6.4 Europe Obesity Market Size, 40-59 Years, By Value, 2019H-2029F (USD Billion & CAGR)
6.6.5 Europe Obesity Market Size, Above 60 Years, By Value, 2019H-2029F (USD Billion & CAGR)
6.7 Europe Obesity Market Segmentation: By Country
6.7.1 United Kingdom Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.7.1.1 United Kingdom Obesity Market, By Gender
6.7.1.2 United Kingdom Obesity Market, By Drug Type
6.7.1.3 United Kingdom Obesity Market, By Age Group
6.7.2 Germany Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.7.2.1 Germany Obesity Market, By Gender
6.7.2.2 Germany Obesity Market, By Drug Type
6.7.2.3 Germany Obesity Market, By Age Group
6.7.3 France Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.7.3.1 France Obesity Market, By Gender
6.7.3.2 France Obesity Market, By Drug Type
6.7.3.3 France Obesity Market, By Age Group
6.7.4 Italy Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.7.4.1 Italy Obesity Market, By Gender
6.7.4.2 Italy Obesity Market, By Drug Type
6.7.4.3 Italy Obesity Market, By Age Group
6.7.5 Spain Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.7.5.1 Spain Obesity Market, By Gender
6.7.5.2 Spain Obesity Market, By Drug Type
6.7.5.3 Spain Obesity Market, By Age Group
6.7.6 Rest of Europe Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.7.6.1 Rest of Europe Obesity Market, By Gender
6.7.6.2 Rest of Europe Obesity Market, By Drug Type
6.7.6.3 Rest of Europe Obesity Market, By Age Group
7. Asia Pacific Obesity Market: Historic and Forecast (2019-2029)
7.1 Asia Pacific Obesity Market: Snapshot
7.2 Asia Pacific Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.3 Asia Pacific Obesity Market: Key Factors
7.4 Asia Pacific Obesity Market Segmentation: By Gender
7.4.1 Asia Pacific Obesity Market, By Gender Overview
7.4.2 Asia Pacific Obesity Market Size, By Male, By Value, 2019H-2029F (USD Billion & CAGR)
7.4.3 Asia Pacific Obesity Market Size, By Female, By Value, 2019H-2029F (USD Billion & CAGR)
7.5 Asia Pacific Obesity Market Segmentation: By Drug Type
7.5.1 Asia Pacific Obesity Market, By Drug Type Overview
7.5.2 Asia Pacific Obesity Market Size, By Appetite Suppressants, By Value, 2019H-2029F (USD Billion & CAGR)
7.5.3 Asia Pacific Obesity Market Size, By Combination Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
7.5.4 Asia Pacific Obesity Market Size, By Malabsorption Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
7.5.5 Asia Pacific Obesity Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
7.6 Asia Pacific Obesity Market Segmentation: By Age Group
7.6.1 Asia Pacific Obesity Market, By Age Group Overview
7.6.2 Asia Pacific Obesity Market Size, 0-18 Years, By Value, 2019H-2029F (USD Billion & CAGR)
7.6.3 Asia Pacific Obesity Market Size, 19-39 Years, By Value, 2019H-2029F (USD Billion & CAGR)
7.6.4 Asia Pacific Obesity Market Size, 40-59 Years, By Value, 2019H-2029F (USD Billion & CAGR)
7.6.5 Asia Pacific Obesity Market Size, Above 60 Years, By Value, 2019H-2029F (USD Billion & CAGR)
7.7 Asia Pacific Obesity Market Segmentation: By Country
7.7.1 China Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.7.1.1 China Obesity Market, By Gender
7.7.1.2 China Obesity Market, By Drug Type
7.7.1.3 China Obesity Market, By Age Group
7.7.2 Japan Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.7.2.1 Japan Obesity Market, By Gender
7.7.2.2 Japan Obesity Market, By Drug Type
7.7.2.3 Japan Obesity Market, By Age Group
7.7.3 Rest of APAC Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.7.3.1 Rest of APAC Obesity Market, By Gender
7.7.3.2 Rest of APAC Obesity Market, By Drug Type
7.7.3.3 Rest of APAC Obesity Market, By Age Group
8. Middle East & Africa Obesity Market: Historic and Forecast (2019-2029)
8.1 Middle East & Africa Obesity Market: Snapshot
8.2 Middle East & Africa Obesity Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
8.3 Middle East & Africa Obesity Market: Key Factors
8.4 Middle East & Africa Obesity Market Segmentation: By Gender
8.4.1 Middle East & Africa Obesity Market, By Gender Overview
8.4.2 Middle East & Africa Obesity Market Size, By Male, By Value, 2019H-2029F (USD Billion & CAGR)
8.4.3 Middle East & Africa Obesity Market Size, By Female, By Value, 2019H-2029F (USD Billion & CAGR)
8.5 Middle East & Africa Obesity Market Segmentation: By Drug Type
8.5.1 Middle East & Africa Obesity Market, By Drug Type Overview
8.5.2 Middle East & Africa Obesity Market Size, By Appetite Suppressants, By Value, 2019H-2029F (USD Billion & CAGR)
8.5.3 Middle East & Africa Obesity Market Size, By Combination Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
8.5.4 Middle East & Africa Obesity Market Size, By Malabsorption Drugs, By Value, 2019H-2029F (USD Billion & CAGR)
8.5.4 Middle East & Africa Obesity Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
8.6.1 Middle East & Africa Obesity Market, By Age Group Overview
8.6.2 Middle East & Africa Obesity Market Size, 0-18 Years, By Value, 2019H-2029F (USD Billion & CAGR)
8.6.3 Middle East & Africa Obesity Market Size, 19-39 Years, By Value, 2019H-2029F (USD Billion & CAGR)
8.6.4 Middle East & Africa Obesity Market Size, 40-59 Years, By Value, 2019H-2029F (USD Billion & CAGR)
8.6.5 Middle East & Africa Obesity Market Size, Above 60 Years, By Value, 2019H-2029F (USD Billion & CAGR)
9. Market Dynamics
9.1 Impact Assessment of Market Dynamics on the Obesity Market
9.2 Drivers
9.3 Restraints
9.4 Trends
10. Industry Ecosystem Analysis
10.1 Macro-Economic Factor Assessment
10.2 Value Chain Analysis
10.3 Porter Analysis
11. Competitive Positioning
11.1 Companies' Product Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of Obesity Market
11.4 Company Profiles
11.4.1 Novo Nordisk
11.4.2 Eli Lilly and Company
11.4.3 Altimmune
11.4.4 Amgen
11.4.5 Carmot
11.4.6 Novartis
11.4.7 Zealand Pharma
11.4.8 AstraZeneca
11.4.9 Sciwind Biosciences
11.4.10 Bristol Myers Squibb
Request Sample 
Request Discount 
Inquire Before Buy
